Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts
- 1 August 2002
- Vol. 132 (2), 149-156
- https://doi.org/10.1067/msy.2002.125169
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- PROLONGED XENOGRAFT SURVIVAL OF ISLETS INFECTED WITH SMALL DOSES OF ADENOVIRUS EXPRESSING CTLA4Ig1Transplantation, 1999
- Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4IgNature Medicine, 1998
- CD40-gp39 INTERACTIONS PLAY A CRITICAL ROLE DURING ALLOGRAFT REJECTIONTransplantation, 1996
- New perspectives of C1328-137-mediated T cell costimulationImmunity, 1995
- MULTIPLE VECTORS EFFECTIVELY ACHIEVE GENE TRANSFER IN A MURINE CARDIAC TRANSPLANTATION MODEL IMMUNOSUPPRESSION WITH TGF-β OR vIL-10Transplantation, 1995
- Functional CD40 on B lymphocytes and dendritic cellsResearch in Immunology, 1994
- Properties of mouse CD40: Cellular distribution of CD40 and B cell activation by monoclonal anti‐mouse CD40 antibodiesEuropean Journal of Immunology, 1994
- ADENOVIRUS-MEDIATED GENE TRANSFER IN THE TRANSPLANT SETTINGTransplantation, 1994
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990